ライブ

CellSingle-cell mapping of regulatory DNA-protein interactions CellPlasma signals of lung tumor promotion for molecular cancer prevention CellDeep learning of functional perturbations from condensate morphology FierceBiotechAt first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts Lonza NewsStipple Bio taps Lonza platform to advance ADC pipeline - The Pharma Letter LabiotechEpisode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media Lonza NewsLonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies - Indian Pharma Post Eli LillyGilead, Merck, Eli Lilly lead $106B biopharma takeover wave in 2026 - MSN Thermo FisherThe Bull Case For Thermo Fisher Scientific (TMO) Could Change Following AI-Enhanced Orbitrap Drug Discovery Launches – Learn Why - Yahoo Finance eLifeThe NTR/prodrug revolution: Tools for controlling cell loss and regeneration Bio-Gene Technology LtdBio-Gene lifts placement size with additional shares and options - TipRanks 10x Genomics BlogThis $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - AOL.com

アーカイブ

最新古い順クリア

@BioPharma Dive

合計 509

情報源 BioPharma Dive

検索 --

BioPharma Dive 2026年5月29日

At ASCO, Merck makes case for a ‘cornerstone’ cancer drug

BioPharma Dive 2026年5月29日

Bristol Myers unveils data for one of its next-gen blood cancer drugs

BioPharma Dive 2026年5月29日

Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks

BioPharma Dive 2026年5月29日

Allogene CEO to step down; Agios drug fails key test

BioPharma Dive 2026年5月29日

Can a chaotic FDA still deliver on faster drug development?

BioPharma Dive 2026年5月29日

Pfizer, Innovent strike $10B cancer drug deal

BioPharma Dive 2026年5月28日

GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’

BioPharma Dive 2026年5月28日

CVS obesity drug deal puts Lilly on equal footing with Novo

BioPharma Dive 2026年5月27日

Verge, following trial failure, rebrands its AI drug discovery ambitions

BioPharma Dive 2026年5月27日

FDA delays decision on AstraZeneca breast cancer pill

BioPharma Dive 2026年5月27日

Cardio drugmaker Kardigan plans to go public

BioPharma Dive 2026年5月27日

Kailera’s three-pronged obesity shot shows promise in early trial

BioPharma Dive 2026年5月27日

Apogee eczema drugs gets Blackstone backing, heads to Phase 3

BioPharma Dive 2026年5月26日

Early data for heart drug affirm Lilly’s billion-dollar bet on Verve

BioPharma Dive 2026年5月26日

Lilly dives into vaccine research with 3 biotech buyouts

BioPharma Dive 2026年5月26日

Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine

BioPharma Dive 2026年5月26日

SR One’s Simeon George on how China is rewriting biotech’s venture playbook

BioPharma Dive 2026年5月26日

Measuring what matters: New priorities in COA selection